Colon cancer, also known as colorectal cancer, is a type of cancer that develops in the colon or rectum, the last part of the large intestine. It often starts as small, noncancerous clumps of cells ...

Researchers found that clinically achievable doses of curcumin, the active compound in turmeric, target and suppress ...

A University of Alberta research team has identified a DNA structure that activates the immune system in cancer cells that ...

A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically ...

No one wants to be diagnosed with or go through the physical and psychological toll of cancer. Which is why, sometimes, it's ...

Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, discusses how early data from ABBV-706 shows up to 50% ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

The Utah father had been documenting his journey with cancer and the birth of his daughter after being first diagnosed at 25.

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

A new cancer drug candidate developed by Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and ...

The collaboration aims to evaluate the combination across three priority tumor types, including RAS mutant non-small cell lung cancer, pancreatic ductal adenocarcinoma and colorectal cancer.

Tumors shrank more with the addition of acoustic cluster therapy to chemotherapy in colorectal liver metastases in the phase 1 ACTIVATE trial. Reflecting on my Son's Graduation as a Previvor. ...